Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. 2015

Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
Department of Vascular Medicine, AMC, Amsterdam, The Netherlands. Electronic address: f.m.valkvander@amc.nl.

Drug delivery to atherosclerotic plaques via liposomal nanoparticles may improve therapeutic agents' risk-benefit ratios. Our paper details the first clinical studies of a liposomal nanoparticle encapsulating prednisolone (LN-PLP) in atherosclerosis. First, PLP's liposomal encapsulation improved its pharmacokinetic profile in humans (n=13) as attested by an increased plasma half-life of 63h (LN-PLP 1.5mg/kg). Second, intravenously infused LN-PLP appeared in 75% of the macrophages isolated from iliofemoral plaques of patients (n=14) referred for vascular surgery in a randomized, placebo-controlled trial. LN-PLP treatment did however not reduce arterial wall permeability or inflammation in patients with atherosclerotic disease (n=30), as assessed by multimodal imaging in a subsequent randomized, placebo-controlled study. In conclusion, we successfully delivered a long-circulating nanoparticle to atherosclerotic plaque macrophages in patients, whereas prednisolone accumulation in atherosclerotic lesions had no anti-inflammatory effect. Nonetheless, the present study provides guidance for development and imaging-assisted evaluation of future nanomedicine in atherosclerosis. BACKGROUND In this study, the authors undertook the first clinical trial using long-circulating liposomal nanoparticle encapsulating prednisolone in patients with atherosclerosis, based on previous animal studies. Despite little evidence of anti-inflammatory effect, the results have provided a starting point for future development of nanomedicine in cardiovascular diseases.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
July 1991, Biochimica et biophysica acta,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
June 1978, Biulleten' eksperimental'noi biologii i meditsiny,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
April 2020, Biomacromolecules,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
January 2003, Audiology & neuro-otology,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
February 1974, Medizinische Klinik,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
January 2023, Nuclear medicine and biology,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
October 2012, International journal of pharmaceutics,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
October 1989, Journal of clinical pharmacology,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
January 1991, Atherosclerosis,
Fleur M van der Valk, and Diederik F van Wijk, and Mark E Lobatto, and Hein J Verberne, and Gert Storm, and Martine C M Willems, and Dink A Legemate, and Aart J Nederveen, and Claudia Calcagno, and Venkatesh Mani, and Sarayu Ramachandran, and Maarten P M Paridaans, and Maarten J Otten, and Geesje M Dallinga-Thie, and Zahi A Fayad, and Max Nieuwdorp, and Dominik M Schulte, and Josbert M Metselaar, and Willem J M Mulder, and Erik S Stroes
February 1982, Cancer research,
Copied contents to your clipboard!